Clinical effects of Portulaca oleracea seeds on dyslipidemia in obese adolescents: a triple-blinded randomized controlled trial
- PMID: 25195352
Clinical effects of Portulaca oleracea seeds on dyslipidemia in obese adolescents: a triple-blinded randomized controlled trial
Abstract
Objective: Childhood obesity is a major public health concern worldwide while the current epidemic may be secondary to over consumption of high-fat, energy-rich foods. Purslane (Portulaca oleracea L.) has been traditionally used in medicine for several antioxidant and anti-atherogenic activities. In this study the anti-dyslipidemic effects of Poleracea was evaluated in obese adolescents.
Methods: In this triple-blinded randomized placebo-controlled clinical trial which was done from July 2011 to June 2012, obese adolescent patients whom were referred to the Isfahan Cardiovascular Research Institute (Iran) were randomly allocated to the two arms of cases and controls. The cases group was asked to take one capsule containing powdered P. oleracea seeds (500 milligrams) two times a day for one month, and the controls group were asked to take identical but placebo (lactose) capsules in the same way. Biochemical parameters including 12-hours fasting serum levels of total cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglycerides (TG) were measured before the initiation and after the completion of the study protocol.
Findings: Total cholesterol, LDL-C, and TG showed statistically significant changes over time (one month) in the P. oleracea group (p < 0.05). However, between-group analysis using general linear model (multivariate) test revealed that the differences in the mentioned parameters between two study groups were statistically significant just for LDL-C and TG, while others did not differ significantly.
Conclusion: P. oleracea L. may have positive effects on serum lipids profile which may be attributed to its polyphenolic and antioxidant compounds. This herbal drug seems to be well-tolerated in adolescent population as well. Further studies are recommended.
Similar articles
-
Clinical Effects of Rhus coriaria Fruits on Dyslipidemia308 in Adolescents: a Triple-blinded Randomized Placebo-controlled Trial.Med Arch. 2014 Oct;68(5):308-12. doi: 10.5455/medarh.2014.68.308-312. Epub 2014 Oct 15. Med Arch. 2014. PMID: 25568560 Free PMC article. Clinical Trial.
-
Clinical Effects of Portulaca Oleracea Seeds on Dyslipidemia in Obese Adolescents: a Triple-blinded Randomized Controlled Trial.Med Arch. 2014 Jun;68(3):195-9. doi: 10.5455/medarh.2014.68.195-199. Epub 2014 May 31. Med Arch. 2014. PMID: 25568533 Free PMC article. Clinical Trial.
-
Effect of Zizyphus jujuba fruits on dyslipidemia in obese adolescents: a triple-masked randomized controlled clinical trial.Med Arch. 2013;67(3):156-9. Med Arch. 2013. PMID: 23848030 Clinical Trial.
-
Pitavastatin: novel effects on lipid parameters.Atheroscler Suppl. 2011 Nov;12(3):277-84. doi: 10.1016/S1567-5688(11)70887-X. Atheroscler Suppl. 2011. PMID: 22152282 Review.
-
Challenges in the pharmacologic management of obesity and secondary dyslipidemia in children and adolescents.Paediatr Drugs. 2013 Oct;15(5):335-42. doi: 10.1007/s40272-013-0028-2. Paediatr Drugs. 2013. PMID: 23677836 Free PMC article. Review.
Cited by
-
Exploring the Impact of Nutrition on Non-Alcoholic Fatty Liver Disease Management: Unveiling the Roles of Various Foods, Food Components, and Compounds.Nutrients. 2023 Jun 22;15(13):2838. doi: 10.3390/nu15132838. Nutrients. 2023. PMID: 37447164 Free PMC article. Review.
-
Clinical Effects of Rhus coriaria Fruits on Dyslipidemia308 in Adolescents: a Triple-blinded Randomized Placebo-controlled Trial.Med Arch. 2014 Oct;68(5):308-12. doi: 10.5455/medarh.2014.68.308-312. Epub 2014 Oct 15. Med Arch. 2014. PMID: 25568560 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous